NEW YORK — GenomeSmart said on Tuesday that specialty medical technology firm Aspira Labs will evaluate its GenomeBrain digital genetic test recommendation platform under a pilot program.
NEW YORK — GenomeSmart said on Tuesday that specialty medical technology firm Aspira Labs will evaluate its GenomeBrain digital genetic test recommendation platform under a pilot program.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.